Scientists in the U.S. have shown that tiny nanoprobes are effective in delivering cancer drugs more directly to tumour cells and the correct cellular compartments.
Scientists in the U.S. have shown that tiny nanoprobes are effective in delivering cancer drugs more directly to tumour cells and the correct cellular compartments.
Purdue University Professor Joseph Irudayaraj and graduate student Jiji Chen said they've determined the nanoprobes, or nanorods, when coated with the breast cancer drug Herceptin, are reaching the endosomes of cells, mimicking the delivery of the drug on its own.
Reduce Risk of Death from Lung Cancer With Breast Cancer Drug
Anti-estrogens may also reduce the risk of dying from lung cancer though essentially used to treat breast cancer, a new study suggests.
Anti-estrogens may also reduce the risk of dying from lung cancer though essentially used to treat breast cancer, a new study suggests.
"We have demonstrated the ability to track these nanoparticles in different cellular compartments of live cells and show where they collect quantitatively," said Irudayaraj.
"Our methods will allow us to calculate the quantities of a drug needed to treat a cancer cell because now we know how these nanoparticles are being distributed to different parts of the cell," Irudayaraj added.
Inefffective New Cancer Drugs Get a 'New Life,' a Pill Makes Them Cancer-fighters
A chemical compound that will turn ineffective new cancer drugs into cancer-fighters has been identified by scientists at the University of Oklahoma Health Sciences Centre.
A chemical compound that will turn ineffective new cancer drugs into cancer-fighters has been identified by scientists at the University of Oklahoma Health Sciences Centre.
An MRI machine can track the magnetic portions of the nanoprobes while a more sensitive microscopy process can detect the gold. The nanoprobes were inserted into live human tumour cells during laboratory testing.
Advertisement
Scientists Show How Anti-cancer Drug Works
The mechanism behind the working of anti-cancer drug called tetrathiomolybdate (tm) has been revealed by Washington, researchers from Northwestern University.
The mechanism behind the working of anti-cancer drug called tetrathiomolybdate (tm) has been revealed by Washington, researchers from Northwestern University.
Cancer treatments often use high drug concentrations that damage healthy cells near a tumour. While Herceptin is attracted to and attaches to the proteins on the surface of breast cancer cells, healthy surrounding cells absorb some of the chemotherapy drugs through normal fluidic intake.
Advertisement
Devising A New Kind of Cancer Drug
An innovative way to disarm a key protein considered to be undruggable has been devised by scientists.
An innovative way to disarm a key protein considered to be undruggable has been devised by scientists.
"Each nanoparticle acts like a deliverer of a mail package, or dose, of the drug directly to the appropriate location," Irudayaraj said.
The results were published early online in the journal ACS Nano.
Source-ANI
TAN
